- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT04817280
COVID-19 in Polish Ice Swimmers. (ICE)
Influence of Ice Swimming on Hardening Against SARS-CoV-2 and Influence of AB0 Rh Blood Type on Viral Resistance in Polish Ice Swimmers.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
The research tool is an original questionnaire compiled by a team of experts conducting the study. The survey includes questions about sociodemographic data, such as age and gender and blood type in AB0 system with Rh factor, and questions about the frequency of ice swimming, the duration of a single session, and since when respondents have been ice swimming. There was also a question about the respondents' compliance with the restrictions and recommendations related to the pandemic and contacts with people with confirmed SARS-CoV-2 infection. In the survey, researchers ask about the infectious symptoms experienced during the pandemic and about being diagnosed with COVID-19 or its exclusion. People who have been ill are asked about the place of treatment.
The questionnaires are collected in traditional form, on the Internet and as scans of documents. Each survey was completely anonymous. The obtained statistical data will be compared with official data on new COVID-19 cases and recoveries at the same time. Official data are published by the Ministry of Health and earlier also by Sanitary and Epidemiological Stations. The main aim of the study was to determine whether ice swimming also increases resistance to SARS-CoV-2 and COVID-19.
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
Dolny Slask
-
Wrocław, Dolny Slask, Polonia, 51-618
- Department of Public Health at Wroclaw Medical University
-
-
Lubuskie
-
Gorzów Wielkopolski, Lubuskie, Polonia, 66-400
- Department of Radiotherapy of Multidisciplinary Provincial Hospital
-
Zielona Góra, Lubuskie, Polonia, 65-031
- Treasury Medical Company
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- ice swimmers
Exclusion Criteria:
- not active ice swimmers
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
|---|---|
|
Ice Swimmers Group.
No intervention.
Data obtained from Polish ice swimmers reported by them retrospectively in the questionnaire.
|
The intervention is not made in the course of a research study.
Ice swimming has been introduced earlier by a given group.
The group was made up of people who already swim in ice.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Assessment of the incidence of COVID-19 among ice swimmers compared to the general population.
Lasso di tempo: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
|
Assessment of the frequency of asymptomatic SARS-CoV-2 infection among ice swimmers compared to the general population.
Lasso di tempo: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
|
Assessment of the frequency of occurrence of particular symptoms of SARS-CoV-2 infection among ice swimmers compared to the general population.
Lasso di tempo: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
|
Assessment of the frequency of COVID-19 treatment in an outpatient, inpatient and intensive care unit among ice swimmers compared to the general population.
Lasso di tempo: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
|
Assessment of the impact of parameters and ice swimming strategies on the likelihood of developing COVID-19, the occurrence of individual symptoms of the disease and the severity of its course.
Lasso di tempo: 47 days.
|
Inference from data obtained from surveys collected among ice swimmers.
|
47 days.
|
|
Assessment of the influence of blood group on susceptibility to SARS-CoV-2 infection among ice swimmers.
Lasso di tempo: 47 days.
|
Inference from data obtained from surveys collected among ice swimmers.
|
47 days.
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Assessment of the immunity of the ice swimmer's immune system compared to the general population.
Lasso di tempo: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
Collaboratori e investigatori
Sponsor
Investigatori
- Direttore dello studio: Sylwia Sulimiera Michalak, MD, PhD, Department of Pharmacology and Toxicology, Medical University of Zielona Gora
- Direttore dello studio: Edyta Wolny-Rokicka, MD, PhD, Department and Center of Radiotherapy, Multidisciplinary Provincial Hospital in Gorzow Wielkopolski
- Cattedra di studio: Andrzej Tukiendorf, Prof., Department of Public Health, Wroclaw Medical University
- Investigatore principale: Lukasz K Wysoczanski, MD, Department of Family Medicine, Wroclaw Medical University
- Investigatore principale: Paulina N Wysoczanska, MD, Department of Family Medicine, Wroclaw Medical University
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Processi patologici
- Infezioni da coronavirus
- Infezioni da Coronaviridae
- Infezioni da Nidovirus
- Infezioni da virus a RNA
- Malattie virali
- Infezioni
- Infezioni delle vie respiratorie
- Malattie delle vie respiratorie
- Polmonite, virale
- Polmonite
- Malattie polmonari
- Attributi della malattia
- Cambiamenti di temperatura corporea
- Grave sindrome respiratoria acuta
- COVID-19
- Ipotermia
- Resistenza alle malattie
Altri numeri di identificazione dello studio
- KB-03/139/2021
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Covid19
-
Anavasi DiagnosticsNon ancora reclutamento
-
Ain Shams UniversityReclutamento
-
Israel Institute for Biological Research (IIBR)Completato
-
Colgate PalmoliveCompletato
-
Christian von BuchwaldCompletato
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdAttivo, non reclutante
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichIscrizione su invito
-
Alexandria UniversityCompletato
-
Erasmus Medical CenterUniversity Medical Center Groningen; Academisch Medisch Centrum - Universiteit... e altri collaboratoriReclutamento
Prove cliniche su Ice Swimming
-
Dow University of Health SciencesNon ancora reclutamentoPulpite sintomatica irreversibile | Effetto crioterapia | Trattamento canalare | Dolore intraoperatorioPakistan
-
Philips Clinical & Medical Affairs GlobalCompletatoIctus | Fibrillazione atriale | Malattia della valvola aortica | Difetto del setto atriale | Forame ovale pervio | Malattia valvolare, cuore | Malattia della valvola mitrale | Malattia della valvola tricuspideStati Uniti
-
IceCure Medical Ltd.CompletatoCarcinoma al senoRepubblica Ceca
-
Boston Scientific CorporationNon ancora reclutamentoAritmia atriale | Ecocardiografia IntracardiacaNuova Zelanda, Malaysia, Grecia, Croazia, Singapore, Polonia, Cechia, Australia
-
Philips Clinical & Medical Affairs GlobalNon ancora reclutamentoDifetto del setto atriale | Forame ovale pervio | Malattia valvolare, cuore | Fibrillazione atriale (FA) | Malattia della valvola tricuspide | CHIUSURA DELL'APPENDICE ATRIALE per FIBRILLAZIONE ATRIALE
-
The Cleveland ClinicReclutamentoFibrillazione atriale | Trombosi dell'appendice atriale sinistraStati Uniti
-
IceCure Medical Ltd.CompletatoCancro al senoStati Uniti
-
University of Erlangen-Nürnberg Medical SchoolGerman Federal Ministry of Education and Research; University of Erlangen-NürnbergSconosciutoMal di schiena | ComunicazioneGermania
-
ConaviCompletato
-
Catholic University of the Sacred HeartEuropean Space Agency (ESA); ASI Agenzia Spaziale Italiana; Programma Nazionale... e altri collaboratoriIscrizione su invitoEquipaggio invernale alla stazione ConcordiaAntartide